Partnering with the AABB Foundation puts your organization at the table with leaders in the field similarly dedicated to providing support for innovative research that will advance transfusion medicine and biotherapies.
“Vitalant believes it’s critically important to continually further the advancement of transfusion medicine and biotherapies, in direct alignment with the Foundation’s purpose. We’re all in this together – driving for better patient outcomes and a sustained blood supply.”
David R. Green, President and CEO, Vitalant
“Fresenius Kabi is honored to support the Foundation as a CORD-level donor. We remain committed to this partnership and our motivation is to support and recognize the advancement of science in transfusion medicine, technologies and biotherapies.”
Dean Gregory, Former President, Medical Devices, Fresenius Kabi
The Council on Research and Development (CORD) comprises major contributors, supports the mission of the Foundation, and offers both financial and intellectual support to strategically drive the Foundation’s activities.
This exclusive circle of donors also engages in critical conversations to shape the future of transfusion medicine and biotherapies.
Two levels of contribution offer recognition benefits, opportunities to create relationships and learn first-hand about current issues critical to the field.
The AABB Foundation thanks our generous contributors for helping us deliver life-changing impact through critical research initiatives.
The AABB Foundation would like to thank the AABB Corporate Partners for their support.
Questions?
Contact the AABB Foundation for more information: +1.301.215.6552 or foundation@aabb.org.
Reminer: Join the Community in Celebrating GivingTuesday
November 26, 2024
New Research From AABB Foundation Alumni Explores RBC Storage
November 25, 2024
AABB Changemakers: Julia Z. Xu, MD, MScGH
September 27, 2024
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
